Scalable Bioreactor Solutions
For Shear-Sensitive Cell Cultures
From Lab to Industrial Scale
From research to industrial production
for multiple cell types
Stem cells, immune cells, organoids, microalgae…
Industrial-Scale Cell Solutions
for Advanced Bioproduction
Scaling, our cutting-edge bioreactor technology eliminates shear stress, ensuring optimal cell growth for cell therapy and cultivated meat production.
Technology
for the Future of
Bioproduction
Few solutions have succeeded in truly overcoming the core limitations of traditional bioreactor systems — especially when it comes to producing fragile cells at industrial scale. Cellura takes a different path.
Our patented rotating bioreactor technology is designed to break through the major barriers of cell culture, particularly shear stress, which has long compromised the viability and function of sensitive cells. Our approach delivers both scalable manufacturing capabilities and high- performance tools for research environments.
From stem cells, organoids, NK, T cells to microalgae and rare cell lines, Cellura’s innovation is powering the next generation of bioproduction across medicine, biotechnology, and sustainable food.
Scalability
Designed for seamless integration in cell therapy & cultivated meat production.
Optimized Mixing Efficiency
Achieves homogeneous gas, nutrient, and cell distribution.
Minimal Shear Stress
Protects fragile cells from mechanical damage.
Effortless 3D Cell Expansion
Our innovation is the ultimate low-shear, cost-effective solution for transitioning from traditional 2D flask culture to advanced 3D bioreactor systems—without disrupting your current workflow.
Latest Insights & Innovations
Stay updated with our lastest news in bioproduction
Cellura is delighted to confirm its participation in Cell & Gene Therapy Europe 2025, one of the most influential global gatherings dedicated to the advancement, industrialization, and long-term impact of…
A key event for R&D and innovation BioFIT is one of Europe’s leading events dedicated to early-stage innovation, technology transfer, licensing and collaborative research in biotechnology and biopharmaceutical sciences. Each…
A scientific and regulatory shift toward in vitro models The global transition away from animal experimentation is accelerating. Both the European Directive 2010/63/EU and the FDA Modernization Act 2.0 actively…
